Current guidelines recommend switching patients with community-acquired pneumonia from IV to oral options once they are clinically stable — or after about three days — but this can be shortened, an April 21 news release from Cleveland Clinic said.
Among 378,041 adult patients from 642 U.S. hospitals between 2010 and 2015, about 22,600 received oral antibiotics earlier than three days and did not note worse outcomes than their counterparts, the study, published April 3 in Clinical Infectious Diseases, found.
“Community-acquired pneumonia is a leading cause of hospitalizations and antibiotic use,” Abhishek Deshpande, MD, PhD, one of the study’s lead authors and an assistant professor of medicine at Cleveland Clinic, said in the release. “Optimizing the delivery of antibiotics is crucial, as prolonged exposure can lead to increased antibiotic resistance and healthcare-associated infections. Our research suggests many more patients could be switched earlier without compromising outcomes.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.